Life Sciences Archive » November, 2021

Life Sciences - November, 2021

298 articles

• NY Says Amazon Should Be Forced To Address COVID Safety
• High Court's Right Flank Floats Chevron Deference Overhaul
• Jury Says BGI Owes Illumina $8M For Infringing DNA Patents
• 'God's Tigress': Feds Query Holmes On Balwani 'Love' Texts
• Biden Vax Mandate Preliminarily Blocked By La. Federal Judge
• FDA Panel Backs Merck COVID Pill For High-Risk Adults
• Split Fed. Circ. Upholds Mylan's Win In Axing Tecfidera Patent
• Behind The Scenes With Opioid Attys At Landmark Jury Trial
• IP Challengers Lose Invalidation Bids After '101 Day' Fight
• Meet The Attys Battling Over The Future Of Abortion Rights
• 11th Circ. Sends Drug Effect Questions To Ala. High Court
• BCLP Partner Jumps To Perkins Coie In DC
• Nevada Pot Shop Faces $487K Fine, Ban Over Stolen Plants
• Med Device Case Highlights Physician IP Deal Best Practices
• Judge Blocks Biden's Contractor Vax Mandate In 3 States
• Judge Says Attys For Biotech Whistleblower Should Get $6M
• Ex-OSI Controller Gets 3 Years For Insider Trading Conviction
• Without Leadership Buy-In, Law Firm DEI Efforts Stand To Fail
• Holmes Says Ex-Theranos Exec Controlled And Abused Her
• J&J's Bankruptcy Move To NJ Cracks Door For Dismissal Bid
• Catalent Can't Duck IP Suit Over Epilepsy Drug Vimpat
• WTO Delays Talks Over IP Waiver Amid New Variant Concerns
• Mallinckrodt Gets Ch. 11 Stay Of Acthar Suits Extended
• CBD Company Slammed With ADA Suit Over Website Access
• Biofrontera Settles Skin Therapy IP Suit On Eve Of Trial
• Patent Eligibility Is Becoming Increasingly Relevant At ITC
• Confronting Origination Credit: Self-Advocacy Tips For Attys
• Big Names Could Stack December's IPO Pipeline
• Hagens Berman Stalling Thalidomide Suits Probe, Clients Say
• Fed. Circ. Affirms PTAB Ax Of Indivior's Suboxone Patent
• As ANDA Suit Venue Options Shrink, Del., NJ Rule For Now
• GOP Lawmakers Urge Tai To Oppose COVID Vaccine IP Waiver
• Ga. Justices Won't Review Ruling That Talc Claims Were Late
• Surgical Robot Co. Must Face Instruments Antitrust Claims
• High Court Delays Mulling Apple, Mylan Fintiv Challenges
• Westlake Pays $1.2B For Epoxy Biz Of Davis Polk-Led Hexion
• Rail Unions Say Amtrak's Vaccine Mandate Is Unlawful
• 7th Circ. Tosses Iraq War Vet's VA Suit As Duplication
• How 'Rocket Dockets' Are Affecting IPR Discretionary Denials
• Convicted Ex-Insys Execs Must Pay $48.3M To Victims
• Novartis Wants Atty DQ'd From MS Drug Patent Row In Del.
• A Real-World Guide To Staying Discovery In Federal Court
• Teva Attorneys Leave Goodwin Procter For Greenberg Traurig
• Pharma Biz Hits Back At Contractors In Contamination Row
• Holmes Admits Adding Pfizer Logo To Reports For Walgreens
• Despite Jury Win, Opioid Attys Predict 'A Long Way To Go'
• Pfizer Says Employee Stole Confidential Docs On COVID Vax
• Amgen Takes Antibody Patents Invalidation To Supreme Court
• Allergan Investors' Attys Claim $30.9M Of Price-Fixing Deal
• Fox Rothschild Nabs IP Partner With Pharma Background
• Ariz. Reaches $14.5M Settlement With Juul Over Youth Vaping
• Del. Chemical Plant Escapes Toxic Waste Suit, For Now
• Monsanto Tells Justices $25M Roundup Verdict Must Fall
• Lawmakers Urge Biden To Stand Firm On COVID IP Waiver
• Rutgers, College Of NJ Aim To Erase Vaccine Mandate Suits
• United Workers Can't Halt Vax Mandate Amid 5th Circ. Appeal
• Pharmacy Giants Fueled Opioid Crisis, Ohio Jury Finds
• Ranbaxy Can't Shake MDL Antitrust Claims As Trial Nears
• Illumina's Bid For $25M Over DNA Tech Patents Goes To Jury
• Sanofi Unit To Pay $180M In Disease Treatment Patent Fight
• Holmes Testifies She Thought Theranos Could Do 'Any Test'
• Fla. Co. Pleads Guilty To Conspiracy To Sell Illegal Products
• CORRECTED: PTAB Axes Patent After Purdue Ch. 11 Delay
• Judge Rejects Probe Of Asbestos Votes In Mallinckrodt Ch. 11
• DOJ-Walmart Opioid Battle Halted As High Court Reviews CSA
• J&J Talc Claimants Vow To End Unit's 'Bad Faith' Ch. 11 Case
• Pesticide Use Targeted In New Senate Farmworker Safety Bill
• Teva Says Mylan Is Just Unhappy About MS Drug Competition
• DL Unit's $2.5B Deal For Kraton Gets US Merger Approval
• Fla. Can't Block Federal Health Care Staff Vaccine Mandate
• Choosing The Right IP Protections For Telehealth Innovations
• Medical Cannabis Co. Akanda Files Confidential IPO Docs
• Convicted Illumina Insider Trader Loses $4.5M Forfeiture Fight
• Quest Diagnostics Fertility Biz Sued Over Data Breach
• Supreme Court Won't Review Kodak Injury Claims From Ch. 11
• Illumina Defends Validity Of DNA Sequencing Patents At Trial
• 3rd Circ. Sinks Heart Monitor Co.'s BCBS Antitrust Case
• Acthar Claimants Seek Mallinckrodt Chapter 11 Vote Probe
• Suzanne Somers Drops QVC Nutritional-Supplement Suit
• Texas Appeals Court OKs Temporary Block Of Delta-8 Ban
• Texas Judge Stands By Ruling In United Airlines Vaccine Fight
• Holmes Tells Jurors Some Investors Didn't Want Theranos Info
• FDA, CDC Panel Clear COVID Boosters For All Adults
• To Vax Or Not To Vax Is Not A Constitutional Question
• How To Draft Earnouts That Avoid Post-Closing Disputes
• Mitigating Inflation's Impact On Commercial Contracts
• Fla. Pharma Co. Brings Trade Secrets Suit Over Cancer Work
• Boston Scientific Investors Told To Get To Heart Of Stock Suit
• Health Hires: Baker Donelson, Proskauer
• Horse-Doping Vet Asks For No Prison With Life In 'Shambles'
• Sorrento Escapes COVID-19 Investor Class Action
• Insurance Tips For Mitigating DOJ Cyber Initiative Risks
• Businesses Appeal £100M CMA Fine For Overpriced Drug
• Fortune Writer Claims Holmes Duped Him As DOJ Wraps Case
• 3 Ex-US Officials Reject 'Willy-Nilly' Virus Vaccine IP Waivers
• IP Forecast: Delaware '101 Day' To Start Off With Natera Battle
• Calif. High Court Leaves $87M Roundup Verdict In Place
• Bayer, Amgen Unit Drop IP Suit Over Cancer Drug Generic
• Purdue Cleared To Pay Gov't Groups Over $12M In Ch. 11 Fees
• New Laws, Suit Step Up Fla. Fight Against Vaccine Mandates
• 'Robust' Process Picked Imerys Claims Rep, Trustee Says
• Hand Sanitizer Co. Settles $2.5M Suit Over Disinfectant Order
• Verrill Adds Lead Prosecutor On Insys Case To Boston Office
• Goodwin Lands Technology Expert From Foley
• NJ Firm Accused Of Overcharging Benicar MDL Clients
• M&A Rulings Provide Guidance On 'Bump-Up' Claim Coverage
• Mallinckrodt Ch. 11 Plan Hearing Won't Restart Monday
• 3 Firms Lead Novo Nordisk's $3.3B Dicerna Buy
• 'Laws Of Chemistry' Trump PTAB, Illumina Rival Tells Jury
• Theranos Patient Got Incorrect HIV Test Result, Jury Told
• Biden Plans To Expand COVID-19 Vaccine Supply By 2022
• Mallinckrodt Denies Manipulating Acthar Market
• Drugmaker Says 11th Circ. Ruling Based On 'Straw Man'
• COVID 'Devastating' For Opioid Epidemic, Wash. Judge Told
• Pfizer's $2.3B Trillium Deal Closes Without FTC Challenge
• Ohio Counties Deride Pharmacies' Opioid Mistrial Bid
• Consumer Counsel Gets $115M From EpiPen Settlement
• $600K For Atty Fees Awarded In Pot Co. Investor Settlement
• Heed These Rules, Or Risk Your Argument On Appeal
• Texas Hospital Workers Fight Vaccine Mandate At 5th Circ.
• Teva Says Dr. Reddy's Broke Deal Over Birth Control Device
• 9th Circ. Backs Removal Order Over Animal Abuse
• Skadden's Allison Brown On J&J's Talc Trial Win In Mo.
• It May Be Time To Abolish Patent Claim Construction Hearings
• Teva, Cooper Cos. Must Face All Claims In Paragard IUD MDL
• Unvaxxed Athletes Settle Religious Claims Against College
• Convicted Insider Trader Must Disclose Atty Communications
• Investors Gave Theranos $96M Despite Due Diligence Gaps
• Michigan Town Ducks Weed Growers' Pot Raid Suit
• Merck, Glenmark Want Jury To Decide Zetia Antitrust Market
• Pharmacies Urge Mistrial In Opioid Case As Jury Deliberates
• Purdue Claimants Say Ch. 11 Appeals Threaten Recoveries
• Medical Device Co. To Pay $10M To End Suit Over Stock Drop
• Pfizer Wants FDA Emergency Approval For COVID Treatment
• Pfizer Must Face Trimmed Robitussin Labeling Suit
• Whistleblowers Defend FCA Suit Against HIG Capital
• FTC Tells High Court Impax Ruling Needs No Review
• What To Include In Orders Governing Remote Arbitration
• Mallinckrodt Says Insurers' Acthar Claims Off By $317M
• NC AG Investigating Puff Bar Over Youth E-Cig Sales
• Fed. Circ. Clears Alkem In Horizon Painkiller IP Row
• Ex-DOD GC Rejoins Wilson Sonsini In Calif.
• Kirkland & Ellis Nabs Environmental Atty From Doughty
• Theranos Investor FOMO Is Due Diligence Lesson, Attys Say
• 3rd Circ. Vexed By Timing Of Cancer Lab's RICO Suit
• Law Firms Plant Feet In DC As Regulatory, IP Landscape Shifts
• Wash. AG Steals Defense Thunder As $95B Opioid Trial Starts
• Lax Pharmacies Fed Opioid Crisis, Jury Told As Trial Ends
• Theranos Investor Emailed Prosecutors During Trial, Jury Told
• Illumina Tells Jury BGI Copied Its DNA Sequencing Patents
• Fla. Judge Denies Injunction Against DOD Vax Mandate
• FDA Scraps Trump-Era Leeway For Lab Test Authorizations
• Mallinckrodt Exec Says Acthar Price Hikes Were Necessary
• Texas Oil Driller Escapes Liability In Rig Worker's Stroke Suit
• 6th Circ. Backs FDA, Won't Let Co.'s E-Cigs Back On Market
• Village Farms Intl. Buys Majority Stake In Quebec Pot Grower
• 9th Circ. Sides With Anthem In Health Coverage Battle
• High Court Won't Hear Breast Implant Suits Against J&J Unit
• Embracing ESG: CBRE GC Talks Effective Compliance Emails
• Imerys Judge Won't OK Mediation Without Clear Rules
• Philips Claims Order A Hurdle To Fixing Sleep Apnea Devices
• Supreme Court Declines To Enter Flanax TM Fight
• Ginkgo Says Milbank Probe Rebuts Short-Seller's Fraud Claim
• Sen. Leahy Announces End To Congressional Career
• 5 Key Details As Drama Surrounds $95B Opioid Trial In Wash.
• EU's Expansion Of Merger Review Authority Poses Catch-22
• Illumina's DNA Patent Dispute With BGI Gets Calif. Jury
• Sanofi Beats Whistleblower Suit From Ex-Sales Reps
• Insurers Say Mallinckrodt Sales Strategy Cost Them $320M
• Convicted Illumina Insider Trader Fights $4.5M Forfeiture
• 7th Circ. Again Asked To Revive Becton Buyers' Antitrust Suit
• 9th Circ. Jurisdiction Ruling Guides On Class Action Strategy
• Amgen Backs Juno's Fed. Circ. Bid To Revive $1.1B Judgment
• United Workers Say Judge Overlooked Harms In Vaccine Fight
• The Hazards Of Female Lawyers Being 'Office Moms'
• J&J's Win In Opioid Health Insurance Class Action Is Affirmed
• 7th Circ. Nixes $8M Verdict In Ex-Prisoner's Med Mal Suit
• Biden Taps Ex-FDA Boss Califf To Lead Agency Again
• Cravath, Baker McKenzie-Led J&J Plans Consumer Biz Spinoff
• $626M Flint Water Deal OK'd, $202M Atty Fee Addressed Later
• Theranos Exec Threatened Investor With Litigation, Jury Told
• United Therapeutics Beats HHS' Discount-Dodging Claims
• Judge Says Patent Fight Over Herbicides Must Be Arbitrated
• FTC Judge Says Amici Offer Nothing New In Illumina Case
• Overdose Reversal Drug Maker Settles FCA Suit For $12.7M
• Fed. Circ. Orders Albright To Transfer Another Patent Case
• FTC Orders 2 Generics Divested In $210M Pharma Deal
• Opioid Litigation's Pillar Theory Is Suddenly Showing Cracks
• Discovery Immunity For Draft Expert Reports Lacks Clarity
• J&J Talc Liability Unit's Ch. 11 Transferred To NJ
• Eon, Sandoz Escape Claims Over Generic Heart Drug
• Paul Weiss Helps General Atlantic Snag $7.8B For Latest Fund
• Fed. Circ. Upholds Roche's Win In Cancer Therapy IP Review
• Arnold & Porter Names New Int'l Arbitration Co-Chair
• Ex-Theranos Lab Chief Doubted Holmes' 'Implausible' Takes
• Freezer Maker Can't Get Redo Of $15M Verdict Over Embryos
• Attys Want $1.8M Cut Of $3M ADHD Antitrust Settlement
• Purdue Agrees Not To Finalize Ch. 11 Plan Until Appeals Done
• Texas Judge Temporarily Blocks State's Delta-8 Ban
• A Phased Approach To In-House Legal Tech Adoption
• Okla. High Court Overturns J&J's $465M Opioid Defeat
• United Workers Can't Ground Airline's Vaccine Mandate
• Fertility Lab Sued Over Switched-Embryo 'Nightmare'
• Sanofi, Whistleblower Settle 19-Year Cancer Drug FCA Battle
• 8th Circ. Won't Block Feds' Kidney Transplant Reform
• High Court Won't Hear Breast Implant Suit Against J&J Unit
• Insurers Claim Mallinckrodt Inflated Acthar Price By $300M
• Mich. Appeals Court Upholds Suspension For Pot Doctor
• Coloplast Inks $2.5B Med Biz Deal With Linklaters-Led PE Firm
• Eye Clinic Can't Avoid Whistleblowers' Kickback Claims
• Qiagen Agrees To Pay $53M To Settle Patent Suit
• What To Watch As USTR Considers Chinese Tariff Exclusions
• DOJ Claims Texas Pharmacy Co. Inflated Ingredient Pricing
• 'Flanax' TM Case Could Bring High Court Clarity On 2 Issues
• Fla. Man Admits To $1M Genetic Testing Kickback Scheme
• Confronting Origination Credit: How Firms Can Redo Policies
• Shkreli's Old Co. Fair Game For Antitrust Trial, Judge Says
• J&J's Ch. 11 Talc Stay Deferred Until Case Venue Is Decided
• 4 BigLaw Players In Elizabeth Holmes' Criminal Fraud Trial
• NJ Judge Pauses Sanctions For Discount-Dodging Drug Cos.
• 2 Sun Pharma US Units To Pay $85M In Generic Drugs MDL
• Bristol-Myers Inks $10M Deal To End Drug Antitrust Claims
• 3rd Circ. Preview: Gun Ad Probe, 'Joke' Tweet Mark November
• Fed. Circ. Won't Let Celgene Challenge Mylan's Generic In NJ
• ITC To Probe Imports Of Cannabis Oil-Vaping Products
• EV Truck Maker Rivian's Potential $9.9B IPO Tops Deep Lineup
• Mallinckrodt Cleared On $94M Ch. 11 Bond Penalty
• J&J Unit's Ch. 11 Committee Approved Over Venue Concerns
• Dental Co. Sues Competitor Over Claims Of Effectiveness
• Ill. Plasma Center Reaches $9.9M Deal To End BIPA Suit
• How To Comply With ABA's New Language Access Guidance
• US Supreme Court To Hear Ala. 'Pill Mill' Conviction Case
• Cancer Patient Urges High Court To Ignore Monsanto Appeal
• UK Litigation Roundup: Here's What You Missed In London
• Hedge Fund Priest Beats SEC Short-And-Distort Claims
• Holmes Cited Walgreens Deal In Rushing Investors, Jury Told
• Cherokee Nation Bashes Pharmacies' Prescription Data Bid
• 6 More States Sue Biden Over Gov't Contractor Vax Mandate
• 5 Takeaways From Drugmakers' Win In Calif. Opioid Trial
• IP Forecast: Google Patent Fight Heads To Texas Jury
• WTO Warns Of Trade's Negative Impact On Climate Change
• Mallinckrodt Can Duck Acthar Royalties In Chapter 11
• FTC Questions Academics' Interest In Backing Illumina
• Jury Awards $1M To Medical Co.'s Buyer Over Soured Deal
• Shkreli Won't Take The Stand At FTC Antitrust Trial
• Kaiser Says Workers Rely On 'Bizarre' Theories In Vax Row
• Miss. AG Says J&J Using Justices' Time To Delay Talc Trial
• Texas Panel Won't End Fen-Phen Atty Malpractice Fight
• Fed. Circ. Revives Scottish University's MRSA Prevention IP
• Novartis Sells $20.7B Stake In Fellow Swiss Pharma Co. Roche
• Fecal Testing Startup Founders Can't Flush SEC Charges
• Boies Said Theranos Tech Was Sound, Investors' Atty Testifies
• Fertilizer Co. Gets Receiver To Help $7M Arbitration Collection
• J&J Unit Says Ch. 11 Stay Extension Needed To Handle Claims
• Novartis Fights Enhanced Damages Bid After $178M Jury Loss
• 3 Practice Tips For Patenting Medical Devices In A Digital Age
• Trader Who Profited From Illegal Illumina Tips Gets 3 Years
• Del. Justices Challenge Shire On $45M 'Windfall' Objection
• Invisalign Maker's $16M Investor Deal Gets Initial Nod
• Ark. Lab Owner Charged With $100M COVID-19 Fraud Scheme
• Best Practices For Hiring And Integrating Freelance Lawyers
• Priest Points Finger At Biotech As SEC Short Sale Trial Wraps
• Ex-Cravath Atty Introduced Rich Clients To Holmes, Jury Told
• CDC Recommends Pfizer Vaccine For Children Aged 5 To 11
• Walmart Tells 5th Circ. Its Pharmacists Are Stuck Over Opioids
• Antitrust Group Says Mallinckrodt Plan Lacks Sufficient Votes
• Teligent's Creditors Decry 'Skewed' Bankruptcy Financing
• How Hueston Hennigan Notched A Landmark Opioid Trial Win
• United Airlines Workers Want Class Cert. In Vax Mandate Suit
• Senators Pitch Pot Research Amendment To Defense Bill
• Generic-Drug Co. Wants Gout Drug Antitrust Suit Tossed
• Contractor Flipped Workout Machines On Amazon, Suit Says
• Buyers Win Backing For Narrow Market In Zetia Generic Suit
• J&J Unit Blasts Bid To Shield Marketing Info In Mesh Row
• Taiwanese Pharma Co. Can't Shake AOP Sanction Bid
• Illumina Says Convicted Insider Trader Broke Investors' Trust
• 5 Post-Theranos Insights On Board Member Oversight
• Pfizer Unit Agrees To Cover $69M Enviro Cleanup In NJ
• NorthShore Can't Dock Pay In Vax Mandate Row
• Arent Fox Settles Unpaid Legal Fees Dispute With Pharma Co.
• DuPont Buys Rogers Corp. In $5.2B Deal Led By 3 Firms
• Jury Awards Boston Scientific $20M In Nevro Patent Trial
• Rite Aid Settles With DOJ To Make Accessible Vaccine Sign-Up
• Drugmakers Not Liable For Calif. Opioid Crisis, Judge Finds
• IPO Market Could End 2021 With A Furious Finish
• Hirshfeld Won't Review Ax Of Arthrex Patent That Started It All
• COVID-19 Origins Inconclusive, US Intelligence Report Says
• Embracing ESG: Cognizant Counsel, CSO Talk Collaboration
• Chancery Tosses Chemours Stock Buyback, Dividend Suit
• Mallinckrodt Ch. 11 Hearing Starts With Valuation Questions
• Priest Urged Investors To 'Run' From Pharma Biz, Jury Hears
• Chicago Police Union Beats Vaccine Mandate — For Now
• Investor Sues Genetics Co. In Del. After Mystery Merger
• Faegre Drinker Adds Ex-Advarra Pharma Regulatory Adviser
• Justices Tackle 'Procedural Morass' In Texas Abortion Cases
• As Social Impact Becomes The Test, Firms Asked To Step Up
• The 2021 Law360 Pulse Social Impact Leaders
• Social Impact Leaders: A Look At Our New Law Firm Ranking